X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs CIPLA - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

CIPLA 
   Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD CIPLA WYETH LTD/
CIPLA
 
P/E (TTM) x 27.7 33.4 82.9% View Chart
P/BV x 5.3 3.4 155.5% View Chart
Dividend Yield % 1.3 0.4 341.3%  

Financials

 WYETH LTD   CIPLA
EQUITY SHARE DATA
    WYETH LTD
Mar-13
CIPLA
Mar-17
WYETH LTD/
CIPLA
5-Yr Chart
Click to enlarge
High Rs1,044622 167.9%   
Low Rs818458 178.5%   
Sales per share (Unadj.) Rs298.6181.9 164.2%  
Earnings per share (Unadj.) Rs57.212.9 444.8%  
Cash flow per share (Unadj.) Rs58.429.3 199.3%  
Dividends per share (Unadj.) Rs17.002.00 850.0%  
Dividend yield (eoy) %1.80.4 493.0%  
Book value per share (Unadj.) Rs249.5155.7 160.2%  
Shares outstanding (eoy) m22.72804.51 2.8%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x3.13.0 105.0%   
Avg P/E ratio x16.342.0 38.8%  
P/CF ratio (eoy) x15.918.4 86.5%  
Price / Book Value ratio x3.73.5 107.6%  
Dividend payout %29.715.5 191.1%   
Avg Mkt Cap Rs m21,157434,516 4.9%   
No. of employees `0000.523.0 2.1%   
Total wages/salary Rs m40026,338 1.5%   
Avg. sales/employee Rs Th13,787.46,349.1 217.2%   
Avg. wages/employee Rs Th813.01,143.0 71.1%   
Avg. net profit/employee Rs Th2,643.3449.3 588.3%   
INCOME DATA
Net Sales Rs m6,783146,302 4.6%  
Other income Rs m3532,287 15.4%   
Total revenues Rs m7,136148,589 4.8%   
Gross profit Rs m1,61724,758 6.5%  
Depreciation Rs m2713,229 0.2%   
Interest Rs m61,594 0.3%   
Profit before tax Rs m1,93812,222 15.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-70 0.0%   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m6321,798 35.2%   
Profit after tax Rs m1,30110,354 12.6%  
Gross profit margin %23.816.9 140.9%  
Effective tax rate %32.614.7 221.8%   
Net profit margin %19.27.1 270.9%  
BALANCE SHEET DATA
Current assets Rs m6,98487,370 8.0%   
Current liabilities Rs m2,05633,081 6.2%   
Net working cap to sales %72.637.1 195.8%  
Current ratio x3.42.6 128.6%  
Inventory Days Days9987 114.1%  
Debtors Days Days2462 38.4%  
Net fixed assets Rs m244111,567 0.2%   
Share capital Rs m2271,609 14.1%   
"Free" reserves Rs m5,441123,645 4.4%   
Net worth Rs m5,668125,254 4.5%   
Long term debt Rs m2536,454 0.1%   
Total assets Rs m7,901209,532 3.8%  
Interest coverage x353.38.7 4,076.1%   
Debt to equity ratio x00.3 1.5%  
Sales to assets ratio x0.90.7 123.0%   
Return on assets %16.55.7 289.9%  
Return on equity %22.98.3 277.6%  
Return on capital %34.08.5 400.5%  
Exports to sales %0.234.2 0.6%   
Imports to sales %36.38.3 435.7%   
Exports (fob) Rs m1550,050 0.0%   
Imports (cif) Rs m2,46512,203 20.2%   
Fx inflow Rs m1551,066 0.0%   
Fx outflow Rs m2,67717,678 15.1%   
Net fx Rs m-2,66233,388 -8.0%   
CASH FLOW
From Operations Rs m92323,824 3.9%  
From Investments Rs m317-13,127 -2.4%  
From Financial Activity Rs m-481-13,239 3.6%  
Net Cashflow Rs m759-2,478 -30.6%  

Share Holding

Indian Promoters % 0.0 16.0 -  
Foreign collaborators % 51.1 20.8 245.7%  
Indian inst/Mut Fund % 11.3 12.2 92.6%  
FIIs % 7.2 23.7 30.4%  
ADR/GDR % 0.0 1.1 -  
Free float % 30.4 26.2 116.0%  
Shareholders   21,978 161,166 13.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   DISHMAN PHARMA  CADILA HEALTHCARE  SUVEN LIFE  PANACEA BIOTECH  WOCKHARDT LTD.  

Compare WYETH LTD With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Weakening Rupee; Key Earnings Report; IDBI Bank, ONGC among Top Stocks in Action Today(Pre-Open)

Indian share markets rose on Friday after rupee recovered from its a 16-month low against the dollar. The S&P BSE Sensex ended at 34,925, up 262 points.

Related Views on News

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Cipla: Extraordinary Income Boosts Net Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

Proceeds from the sale of the South African animal business bolstered Cipla's net profits for the quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD - ORCHID PHARMA LTD COMPARISON

COMPARE WYETH LTD WITH

MARKET STATS